HIGHER MELPHALAN EXPOSURE IS ASSOCIATED WITH IMPROVED OVERALL SURVIVAL FOR MYELOMA PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANT

被引：6
|
作者：
Shaw, P. J. [1 ,2 ]
Nath, C. E. [1 ]
Nivison-Smith, I [3 ]
Joshua, D. E. [2 ,4 ]
Kerridge, I. H. [2 ,5 ]
Presgrave, P. [6 ]
Tiley, C. R. [7 ]
Kwan, Y. L. [8 ]
Trotman, J. [2 ,8 ]
机构：
[1] Childrens Hosp Westmead, Sydney, NSW, Australia
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] St Vincents Hosp, Sydney, NSW 2010, Australia
[4] Royal Prince Alfred Hosp, Sydney, NSW, Australia
[5] Royal N Shore Hosp, Sydney, NSW, Australia
[6] Wollongong Hosp, Wollongong, NSW, Australia
[7] Gosford Hosp, Gosford, England
[8] Concord Hosp, Sydney, NSW, Australia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2012年 / 18卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2011.12.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [1] High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation
    Nath, Christa E.
    Trotman, Judith
    Tiley, Campbell
    Presgrave, Peter
    Joshua, Douglas
    Kerridge, Ian
    Kwan, Yiu Lam
    Gurney, Howard
    McLachlan, Andrew J.
    Earl, John W.
    Nivison-Smith, Ian
    Zeng, Lihua
    Shaw, Peter J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (01) : 149 - 159
  • [2] EXPOSURE-TARGETED MELPHALAN DOSING INDIV IDULIZ ATION IN PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS TRANSPLANT.
    Kim, K.
    Guo, Y.
    Hill, K.
    Abbott, N.
    Irby, D.
    Hofmeister, C.
    Patel, P.
    Sweiss, K.
    Phelps, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S35 - S36
  • [3] Higher Skeletal Muscle Index Is Associated with Improved Overall Survival in Older Patients with Sarcopenia Undergoing Allogeneic Stem Cell Transplant
    Gaulin, Charles
    Langlais, Blake T.
    Mountjoy, Luke
    Korfiatis, Panagiotis
    Tan, Nelly
    Leis, Jose F.
    Khera, Nandita
    Noel, Pierre
    Sproat, Lisa Z.
    Jain, Tania
    Palmer, Jeanne M.
    BLOOD, 2021, 138
  • [4] Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era
    Sweiss, Karen
    Oh, Annie
    Calip, Gregory
    Rondelli, Damiano
    Patel, Pritesh Rajni
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S138 - S138
  • [5] Improved Survival in African American Patients Undergoing Autologous Transplant for Multiple Myeloma in the Chemotherapy and Novel Agent Era
    Sweiss, Karen
    Oh, Annie L.
    Calip, Gregory S.
    Rondelli, Damiano
    Patel, Pritesh R.
    BLOOD, 2016, 128 (22)
  • [6] Effect of Melphalan Exposure in Patients with Lymphoma Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT)
    Lin, Andrew
    Dahi, Parastoo B.
    Flynn, Jessica
    Uruburo, Christian
    Mcgeary, Ian
    Schofield, Ryan
    Bhatt, Valkal
    DeRespiris, Lauren
    Figgins, Bradley
    Griffin, Meagan
    Lau, Carmen
    Proli, Anthony J.
    Carlow, Dean
    Cho, Christina
    Lahoud, Oscar Boutros
    Perales, Miguel
    Sauter, Craig S.
    Scordo, Michael
    Shah, Gunjan L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S230 - S231
  • [7] Melphalan-based autologous transplant in octogenarian multiple myeloma patients
    Saini, Neeraj Y.
    Patel, Romil
    Varma, Ankur
    Bashir, Qaiser
    Delgado, Ruby
    Rondon, Gabriela
    Popat, Uday R.
    Hosing, Chitra M.
    Nieto, Yago
    Kebriaei, Partow
    Alousi, Amin M.
    Ahmed, Sairah
    Weber, Donna M.
    Thomas, Sheeba K.
    Lee, Hans C.
    Manasanch, Elisabet E.
    Patel, Krina K.
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (01) : E2 - E5
  • [8] Phase 1 Trial of AUC-Targeted Melphalan in Myeloma Patients Undergoing Autologous Transplant (The MyMel Study)
    Sweiss, Karen
    Patel, Pritesh
    Guo, Janet
    Kim, Kyeongmin
    Hill, Kasey
    Abbott, Nicole
    Johnson, Jeremy
    Irby, Donald
    Quigley, John G.
    Rondelli, Damiano
    Harvey, R. Donald
    Nooka, Ajay K.
    Dhodapkar, Madhav
    Kaufman, Jonathan L.
    Joseph, Nisha S.
    Lonial, Sagar
    Sborov, Douglas W.
    Phelps, Mitch A.
    Hofmeister, Craig C.
    BLOOD, 2022, 140 : 5988 - 5990
  • [9] Impact of autologous stem cell transplant in myeloma patients on renal function and overall survival.
    Abudayyeh, Ala
    Abdelrahim, Maen
    Lin, Heather Y.
    Saliba, Rima
    Martinez, Charles
    Delgado, Ruby
    Page, Valda D.
    Sanders, Paul W.
    Qazilbash, Muzaffar H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] PHARMACOKINETICS AND PHARMACODYNAMICS OF HIGH DOSE MELPHALAN IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT.
    Cho, Y.
    Wang, J.
    Gao, Y.
    Li, J.
    Lamprecht, M.
    Jukich, M.
    Schaaf, L. J.
    Poi, M.
    Hofmeister, C. C.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S38 - S38
12345